Published on Web 12/21/2004
Synthesis of Postulated Molecular Probes: Stereoselective
Free-Radical-Mediated C-Glycosylation in Tandem with
Hydrogen Transfer
Yvan Guindon,* Mohammed Bencheqroun, and Abderrahim Bouzide
Contribution from the Bio-organic Chemistry Laboratory, Institut de recherches cliniques de
Montre´al (IRCM), 110 aVenue des Pins Ouest, Montre´al, Que´bec, Canada H2W 1R7,
Department of Chemistry and Department of Pharmacology, UniVersite´ de Montre´al, C.P. 6128,
succursale Centre-Ville, Montre´al, Que´bec, Canada H3C 3J7, and Department of Chemistry,
McGill UniVersity, 801 Sherbrooke Street West, Montre´al, Que´bec, Canada H3A 2K6
Received June 18, 2004; E-mail: guindoy@ircm.qc.ca
Abstract: Reported herein is a strategy employing an addition reaction in tandem with a hydrogen-transfer
reaction for the elaboration of C-glycoside-based sialyl Lewis X (sLeX) analogues. Significant stereocontrol
was noted when alkyl radicals were reacted with a series of alkoxytaconates. Transition states were proposed
to explain the obtained selectivity. Further reaction between an anomeric-centered fucosyl-derived radical
and a galactosylated hydroxytaconate provided easy access to C,O-diglycosides as mimics of sLeX. In
this case, two 1,3-distant stereocenters were created with high diastereoselectivity using free radical
intermediates in a tandem process.
The present study stems from our interest in what could
appear to be unrelated scientific issues: the discovery of new
synthetic methodologies that allow for diastereoselective
modifications1-3 of acyclic free radical intermediates, and the
development of sialyl Lewis X (sLeX) mimetics as antagonists
of E- and P-selectins. The latter originates from our interest in
altering the biological effects mediated by the interaction
between posttranslationally modified proteins (e.g., glycopro-
teins) and their receptors.4
The selectin-dependent vascular adhesion of neutrophils, in
response to pro-inflammatory stimuli, is an example of such.
Disrupting the interactions between E- and P-selectins and their
respective ligands, ESL-1 (E-selectin ligand-1) and PSGL-1 (P-
selectin glycoprotein ligand-1), which are located at the surface
of neutrophils and malignant cells, is believed to be promising
as a new treatment for inflammatory diseases5 or certain forms
of invasive cancer.6
At the molecular level, recent X-ray diffraction analysis of
sLeX (alone as well as attached to the PSGL-1 N-terminus)
bound to P-selectin clearly established7 the main pharmaco-
phores to be the sialylated galactose (NeuAc-Gal) and fucose
(Fuc) subunits through electrostatic attraction and H-bonding,
the N-acetylglucosamine (GlcNAc) only acting as a tether.
Similar conclusions were empirically reached through structure-
activity relationship studies, aimed at preventing the interactions
between E- and P-selectins and their sLeX-containing ligands,
as the replacement of the GlcNAc subunit of sLeX, while
unattached to the protein, by different tethers (cyclic as well as
acyclic) led to potent antagonists in competition-based assays.8
(1) For reviews on the synthetic usefulness of free-radical-mediated reactions
see: (a) Radicals in Organic Synthesis, Volume 1: Basic Principles;
Renaud, P., Sibi, M. P., Eds/; Wiley-VCH: Weinheim, Germany, 2001.
(b) Stereochemistry of Radical Reactions: Concepts Guidelines, and
Synthetic Applications; Curran, D. P., Porter, N. A., Giese, B., Eds.; Wiley-
VCH: New York, 1996.
(2) For stereoselective free-radical-based hydrogen-transfer reactions, see: (a)
Guindon, Y.; Murtagh, L.; Caron, V.; Landry, S. R.; Jung, G.; Bencheqroun,
M.; Faucher, A.-M.; Gue´rin, B. J. Org. Chem. 2001, 66, 5427. (b) Bouvier,
J.-P.; Jung, G.; Liu, Z.; Gue´rin, B.; Guindon, Y. Org. Lett. 2001, 3, 1391.
(c) Guindon, Y.; Faucher, A.-M.; Bourque, EÄ .; Caron, V.; Jung, G.; Landry,
S. R. J. Org. Chem. 1997, 62, 9276. (d) Guindon, Y.; Rancourt, J. J. Org.
Chem. 1998, 63, 6554. (e) Guindon, Y.; Liu, Z.; Jung, G. J. Am. Chem.
Soc. 1997, 119, 9289. (f) Guindon, Y.; Slassi, A.; Rancourt, J.; Bantle, G.;
Bencheqroun, M.; Murtagh, L.; Ghiro, E.; Jung, G. J. Org. Chem. 1995,
60, 288. (g) Guindon, Y.; Yoakim, C.; Gorys, V.; Ogilvie, W. W.; Delorme,
D.; Renaud, J.; Robinson, G.; Lavalle´e, J.-F.; Slassi, A.; Jung, G.; Rancourt,
J.; Durkin, K.; Liotta, D. J. Org. Chem. 1994, 59, 1166. (h) Giese, B.;
Damm, W.; Wetterich, F.; Zeitz, H. G.; Rancourt, J.; Guindon, Y.
Tetrahedron Lett. 1993, 34, 5885. (i) Guindon, Y.; Lavalle´e, J.-F.; Llinas-
Brunet, M.; Horner, G.; Rancourt, J. J. Am. Chem. Soc. 1991, 113, 9701.
(3) For stereoselective free-radical-based allylation reactions, see: (a) Guindon,
Y.; Houde, K.; Pre´vost, M.; Cardinal-David, B.; Landry, S. R.; Daoust,
B.; Bencheqroun, M.; Gue´rin, B. J. Am. Chem. Soc. 2001, 123, 8496. (b)
Gue´rin, B.; Chabot, C.; Mackintosh, N.; Guindon, Y. Can. J. Chem. 2000,
78, 852. (d) Guindon, Y.; Jung, G.; Gue´rin, B.; Ogilvie, W. W. Synlett
1998, 213. (e) Guindon, Y.; Gue´rin, B.; Chabot, C.; Ogilvie, W. W. J. Am.
Chem. Soc. 1996, 118, 12528. (f) Guindon, Y.; Gue´rin, B.; Chabot, C.;
Mackintosh, N.; Ogilvie, W. W. Synlett 1995, 449.
(4) (a) Bhunia, A.; Jayalakshmi, V.; Benie, A. J.; Schuster, O.; Kelm, S.; Rama
Krishna, N.; Peters, T. Carbohydr. Res. 2004, 339, 259. (b) Ideo, H.; Seko,
A.; Ishizuka, I.; Yamashita, K. Glycobiology 2003, 13, 713R. (c) Thomas,
B. E.; Kaila, N. Med. Res. ReV. 2002, 22, 566. (d) Beum, P. V.; Cheng, P.
W. AdV. Exp. Med. Biol. 2001, 491, 279.
(5) Alper, J. Science 2003, 301, 159.
(6) Hopfner, M.; Alban, S.; Schumacher, G.; Rothe, U.; Bendas, G. J. Pharm.
Pharmacol. 2003, 55, 697.
(7) Somers, W. S.; Tang, J.; Shaw, G. D.; Camphausen, R. T. Cell 2000, 103,
467.
9
554
J. AM. CHEM. SOC. 2005, 127, 554-558
10.1021/ja046389y CCC: $30.25 © 2005 American Chemical Society